We are live on ! Find out more
NTC

NF Trinity Capital Portfolio holdings

AUM $626M
1-Year Est. Return 3.16%
This Fund
S&P 500
This Quarter Est. Return
+0.07%
1 Year Est. Return
+3.16%
3 Year Est. Return
+49.61%
5 Year Est. Return
10 Year Est. Return
AUM
$757M
AUM Growth
+$25.9M
Cap. Flow
+$34.7M
Cap. Flow %
4.59%
Top 10 Hldgs %
60.04%
Holding
63
New
2
Increased
12
Reduced
9
Closed
7

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$22.6M
2
JD icon
JD.com
JD
+$22.3M
3
BIDU icon
Baidu
BIDU
+$10.3M
4
EDU icon
New Oriental
EDU
+$8.66M
5
ON icon
ON Semiconductor
ON
+$6.08M

Sector Composition

Rank Sector Weight
1 Communication Services 26.43%
2 Consumer Discretionary 23.18%
3 Healthcare 17.17%
4 Technology 13.27%
5 Financials 12.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EDU icon
26
New Oriental
EDU
$7.82B
$7.73M 1.02%
+104,416
New +$8.66M
FNSR
27
DELISTED
Finisar Corp
FNSR
$7.45M 0.98%
391,000
LBTYA icon
28
Liberty Global Class A
LBTYA
$3.52B
$6.87M 0.91%
237,371
GILD icon
29
Gilead Sciences
GILD
$167B
$6.71M 0.89%
86,959
MELI icon
30
Mercado Libre
MELI
$92B
$6.47M 0.85%
19,000
+9,000
+90% +$3.05M
APLS
31
DELISTED
Apellis Pharmaceuticals
APLS
$6.35M 0.84%
357,142
OPTU
32
Optimum Communications Inc
OPTU
$337M
$6.15M 0.81%
339,042
DB icon
33
Deutsche Bank
DB
$67.3B
$6.04M 0.8%
533,225
TAL icon
34
TAL Education Group
TAL
$5.68B
$5.88M 0.78%
228,791
+101,500
+80% +$3.28M
BMY icon
35
Bristol-Myers Squibb
BMY
$124B
$5.77M 0.76%
93,000
IBB icon
36
iShares Biotechnology ETF
IBB
$9.23B
$5.27M 0.7%
43,200
-21,750
-33% -$2.56M
PM icon
37
Philip Morris
PM
$301B
$5.14M 0.68%
63,000
ZAYO
38
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$5.03M 0.67%
+145,000
New +$5.29M
SAGE
39
DELISTED
Sage Therapeutics
SAGE
$4.59M 0.61%
32,506
VTRS icon
40
Viatris
VTRS
$20.1B
$3.66M 0.48%
100,000
SLB icon
41
SLB Ltd
SLB
$70.3B
$3.38M 0.45%
55,500
TSRO
42
DELISTED
TESARO, Inc.
TSRO
$3.31M 0.44%
84,905
MNK
43
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$2.99M 0.4%
102,000
+45,000
+79% +$1.27M
HIMX
44
Himax Technologies
HIMX
$2.23B
$2.76M 0.37%
470,000
DNLI icon
45
Denali Therapeutics
DNLI
$3.7B
$2.44M 0.32%
112,273
ZEN
46
DELISTED
ZENDESK INC
ZEN
$2.44M 0.32%
34,328
INCY icon
47
Incyte
INCY
$23.4B
$2.14M 0.28%
31,000
IOVA icon
48
Iovance Biotherapeutics
IOVA
$2.23B
$1.41M 0.19%
124,854
TEVA icon
49
Teva Pharmaceuticals
TEVA
$37.3B
$1.14M 0.15%
53,000
SYBX
50
DELISTED
Synlogic
SYBX
$975K 0.13%
4,576

Similar funds

NF Trinity Capital's Q3 2018 Portfolio in Review

As of Q3 2018, NF Trinity Capital held 63 positions worth $757M, up 3.5% from $731M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

NF Trinity Capital deployed $34.7M of net new capital in Q3 2018, opening 2 new positions and adding to 12 existing holdings. Its largest new stake was New Oriental: 104,416 shares worth $7.73M.

By sector, the portfolio is most concentrated in Communication Services at 26% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Walt Disney, an estimated $5.05M trimmed.

  • NF Trinity Capital's largest Q3 2018 buy was New Oriental: 104,416 shares worth $7.73M.
  • NF Trinity Capital added most to Alibaba in Q3 2018, an estimated $22.6M increase.
  • NF Trinity Capital's biggest Q3 2018 reduction was Walt Disney, cutting an estimated $5.05M.
  • NF Trinity Capital fully exited Lockheed Martin in Q3 2018, selling an estimated $8.86M.
  • NF Trinity Capital's ten largest holdings make up 60% of its $757M portfolio in Q3 2018.
  • NF Trinity Capital opened 2 new positions and closed 7 in Q3 2018.
  • NF Trinity Capital's portfolio value rose 3.5% quarter-over-quarter to $757M.

Based on NF Trinity Capital's 13F filing for Q3 2018, filed 8 Nov 2018.